PA-824-moxifloxacin-pyranzinamide (PaMZ')

See the following -

CSIR Tuberculosis Drug Project Enters Phase II Clinical Trials

Nikita Mehta | Live Mint | March 25, 2014

The Council of Scientific and Industrial Research’s (CSIR) open source drug discovery (OSDD) project on Monday handed over a new drug combination to the Lala Ram Sarup TB Hospital in New Delhi to take it forward for so-called Phase IIB clinical trials to study the efficacy of the drug that will target multi-drug resistant tuberculosis in Indian patients.

Read More »